Results
25
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
25 companies
Organigram Global
Market Cap: CA$202.0m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.59
7D
7.4%
1Y
-37.9%
Grown Rogue International
Market Cap: CA$122.7m
A craft cannabis company, focuses on premium flower and flower-derived products.
GRIN
CA$0.64
7D
8.5%
1Y
-33.3%
Satellos Bioscience
Market Cap: CA$114.4m
A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$0.66
7D
3.1%
1Y
50.0%
Auxly Cannabis Group
Market Cap: CA$105.3m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.085
7D
6.3%
1Y
70.0%
Simply Better Brands
Market Cap: CA$87.9m
Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.
SBBC
CA$0.87
7D
-6.5%
1Y
148.6%
Medexus Pharmaceuticals
Market Cap: CA$83.9m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.77
7D
8.6%
1Y
48.9%
Medicenna Therapeutics
Market Cap: CA$81.3m
An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.
MDNA
CA$1.05
7D
-4.5%
1Y
-46.2%
Simply Solventless Concentrates
Market Cap: CA$69.3m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.65
7D
14.0%
1Y
170.8%
MTL Cannabis
Market Cap: CA$39.8m
Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.
MTLC
CA$0.33
7D
-2.9%
1Y
10.0%
Sona Nanotech
Market Cap: CA$30.4m
Operates as a nanotechnology life sciences company.
SONA
CA$0.30
7D
11.1%
1Y
-28.6%
Rubicon Organics
Market Cap: CA$26.7m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada.
ROMJ
CA$0.47
7D
5.6%
1Y
25.0%
PreveCeutical Medical
Market Cap: CA$16.4m
A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.
PREV
CA$0.025
7D
-16.7%
1Y
0%
Telescope Innovations
Market Cap: CA$14.0m
A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.
TELI
CA$0.29
7D
0%
1Y
-17.1%
Rakovina Therapeutics
Market Cap: CA$7.0m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.05
7D
11.1%
1Y
-44.4%
XORTX Therapeutics
Market Cap: CA$5.9m
A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.
XRTX
CA$1.45
7D
12.4%
1Y
-59.9%
Xebra Brands
Market Cap: CA$5.4m
Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.
XBRA
CA$0.08
7D
6.7%
1Y
-20.0%
Delivra Health Brands
Market Cap: CA$5.0m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.16
7D
0%
1Y
-60.0%
Blueberries Medical
Market Cap: CA$5.0m
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
BBM
CA$0.01
7D
0%
1Y
-33.3%
Marvel Biosciences
Market Cap: CA$4.9m
A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
MRVL
CA$0.10
7D
5.3%
1Y
-25.9%
Rize Oncology
Market Cap: CA$3.0m
A pharmaceutical company, develops oncology therapies for the treatment of soft tissue sarcoma.
RIZE
CA$0.03
7D
-50.0%
1Y
n/a
Algernon Pharmaceuticals
Market Cap: CA$2.2m
Operates as a clinical stage pharmaceutical development company in Canada and Australia.
AGN
CA$0.08
7D
-5.9%
1Y
-33.3%
RAMM Pharma
Market Cap: CA$1.8m
Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.
RAMM
CA$0.015
7D
0%
1Y
-75.0%
Restart Life Sciences
Market Cap: CA$1.5m
Through its subsidiaries, operates as a biotechnology company worldwide.
HEAL
CA$0.05
7D
-16.7%
1Y
-66.7%
MindBio Therapeutics
Market Cap: CA$1.4m
Operates as a clinical stage drug development company in Australasia.
MBIO
CA$0.01
7D
0%
1Y
-81.8%
Jolt Health
Market Cap: CA$700.1k
Operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada, the Netherlands, rest of Europe, and Jamaica.
JOLT
CA$0.11
7D
4.8%
1Y
10.0%